Scientific rationale for a higher dose of nusinersen

Richard S. Finkel, Monique M. Ryan, Samuel Ignacio Pascual Pascual, John W. Day, Eugenio Mercuri, Darryl C. De Vivo, Richard Foster, Jacqueline Montes, Juliana Gurgel‐Giannetti, Drew MacCannell, Zdenek Berger

Open source

DOI: 10.1002/acn3.51562
Published: 2022-05-13
Container: Annals of Clinical and Translational Neurology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/acn3.51562,
  title = {Scientific rationale for a higher dose of nusinersen},
  author = {Richard S. Finkel and Monique M. Ryan and Samuel Ignacio Pascual Pascual and John W. Day and Eugenio Mercuri and Darryl C. De Vivo and Richard Foster and Jacqueline Montes and Juliana Gurgel‐Giannetti and Drew MacCannell and Zdenek Berger},
  year = {2022},
  journal = {Annals of Clinical and Translational Neurology},
  doi = {10.1002/acn3.51562},
  url = {https://doi.org/10.1002/acn3.51562}
}

RIS

TY  - JOUR
TI  - Scientific rationale for a higher dose of nusinersen
AU  - Richard S. Finkel
AU  - Monique M. Ryan
AU  - Samuel Ignacio Pascual Pascual
AU  - John W. Day
AU  - Eugenio Mercuri
AU  - Darryl C. De Vivo
AU  - Richard Foster
AU  - Jacqueline Montes
AU  - Juliana Gurgel‐Giannetti
AU  - Drew MacCannell
AU  - Zdenek Berger
PY  - 2022
JO  - Annals of Clinical and Translational Neurology
DO  - 10.1002/acn3.51562
UR  - https://doi.org/10.1002/acn3.51562
ER  -

APA

Finkel, R. S., Ryan, M. M., Pascual, S. I. P., Day, J. W., Mercuri, E., Vivo, D. C. D., Foster, R., Montes, J., Gurgel‐Giannetti, J., MacCannell, D., & Berger, Z. (2022). Scientific rationale for a higher dose of nusinersen. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.51562

Source records

crossref · retrieved 2026-09-25T08:15:38.024Z